Intellia Therapeutics Claimed Company
Intellia Therapeutics is a leading genome editing company focused on developing proprietary, curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course, and through improved cell therapies that can treat cancer and immunological diseases, or can replace patients’ diseased cells. The combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. read more
HR or Marketing? Claim Your Free Employer Account
Intellia Therapeutics Mission, Vision & Values
Intellia Therapeutics Mission Statement
Developing curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Intellia Therapeutics Vision Statement
No one has added Intellia Therapeutics' vision statement yet.
Intellia Therapeutics Values
- One
- Explore
- Disrupt
- Deliver
Mission, Vision & Values at Similar Size Companies in Boston
×